
Chemicals & Agriculture · NSE
Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company engaged in the manufacturing, formulation, supply, and packaging of a wide range of pesticides. The company’s product portfolio includes insecticides, herbicides, fungicides, and plant growth regulators, which are distributed across India and exported to over 15 countries, including Australia, Germany, Kenya, and Vietnam. Operating in a sector focused on enhancing crop yield and quality, Aristo Bio-Tech delivers its products across 20 Indian states and supports global agricultural productivity. The company is ISO 9001:2015 certified for its quality management system and also provides contract manufacturing, job work, and toll manufacturing services for crop protection companies.
Price Band
₹72
Issue Size
₹13.05 Cr
Lot Size
1600 shares
GMP
+59.7%
Est. Listing
₹115
at current GMP
Subscribed
217.72x
overall
Open
16 Jan 2023
Close
19 Jan 2023
Allotment
25 Jan 2023
Refund
26 Jan 2023
Demat Credit
27 Jan 2023
Listing
30 Jan 2023
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹72
Band: ₹72
Estimated Listing Price
₹115
Upper price + GMP
Lot Size
1600 shares
Min investment ₹1,15,200
Estimated Profit / Lot
₹68,800
1600 × ₹43
Grey Market Premium trend
+₹43
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹43 | 59.7% | ₹115 |
| 30 Oct 2026 | +₹43 | 59.7% | ₹115 |
| 29 Oct 2026 | +₹39 | 53.8% | ₹111 |
GMP is unofficial market data. Not a guarantee of listing performance.
Aristo Bio-Tech and Lifescience Limited is bringing an initial public offering (IPO) in the Chemicals & Agriculture sector with an aggregate issue size of ₹13.05 Crores. The shares are offered at a price band of ₹72 to ₹72 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2023-01-19, the basis of allotment is scheduled to be finalized on 2023-01-25. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
The latest grey market premium for Aristo Bio-Tech and Lifescience Limited IPO is ₹43, which indicates an expected listing price of ₹115.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.